Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-10 · accession 0001209191-22-003046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-12 | 2022-01-10 | TVTX | Clague Laura | CFO | A - Grant | $0.00 | +7,500 | 38.8K | +24% | $0 | |
| 2022-01-12 | 2022-01-11 | TVTX | Clague Laura | CFO | S - Sale | $27.40 | -7,500 | 31.3K | -19% | -$205.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-10 | A | A | 7,500 | $0.00 | 38,816 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-11 | S | D | 7,500 | $27.40 | 31,316 | D | — | — |